GUANZE MEDICAL：致非登記股東的通知信函及回條 - 2023 年報、通函包括股東週年大會通告及代表委任表格及環境、社會及管治報告之發佈通知

Guanze Medical Information Industry (Holding) Co., Ltd. (Incorporated in the Cayman Islands with limited liability) (Stock code股份代號：2427) NOTIFICATION LETTER 通知信函30 April 2024 Dear Non-registered holders, Guanze Medical Information Industry (Holding) Co., Ltd. (the “Company”) –Notice of Publication of the 2023 Annual Report and Circular including Notice of Annual General Meeting (the “Current Corporate Communications”) and the Environmental, Social and Governance Report (the “2023 ESGReport”) The Current Corporate Communications of the Company have been published in English and Chinese languages and are available on the website of The Stock Exchange of Hong Kong Limited at (the “HKEx’s Website”) and the Company’s website at (the “Company’s Website”). If you have any difficulty gaining access to the Current Corporate Communications posted on the Company’s Website or the HKEx’s Website f or any reason, or would like to receive a printed version of the Current Corporate Communications, please send your request (specifying your name, address and request) by email at guanzemedicalinformation.ecom@computershare.com.hk or by notice in writing to the Company’s Hong Kong share registrar (the “ Share Registrar”), Computershare Hong Kong Investor Services Limited, at 17MFloor, Hopewell Centre,183 Queen’s Road East, Wan Chai, Hong Kong. The Company will promptly upon receipt of your request send the Current Corporate Communications to you in printed form free of charge. The Company’s 2023 ESGReport has been published in English and Chinese languages and is available in electronic form only on the HKEx’s Website and the Company’s Website. If you wish to receive a printed version of the Company’s 2023 ESGReport free of charge, please send your request (specifying your name, address and request) by email or by notice in writing to the Share Registrar at the above email or address respectively. Arrangement of Electronic Dissemination of Corporate Communications Pursuant to Rule 2.07A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”) under the expansion of paperless listing regime and electronic dissemination of corporate communications that came into effect on 31 December 2023, the Company is writing to inform you that the Company has adopted electronic dissemination of corporate communications (the “Corporate Communications”), which mean any documents issued or to be issued by the Company for the information or action of holders of any of its securities, including but not limited to (a) the directors’ report, its annual accounts together with a copy of the auditors’ report and, where applicable, its summary financial report; (b) the interim report and, where applicable, its summary interim report; (c) a notice of meeting; (d) a listing document; (e) a circular and (f) a proxy form. Please note that both the English and Chinese versions of all future Corporate Communications will be available electronically (the “Website Versions”) on the website of the Company at and the HKEXnews website at (the “Websites”) in place of printed copies. Upon making necessary amendments to the articles of association of the Company, the Company will not send notifications of availability of the Website Versions of the Corporate Communications to the shareholders of the Company. The shareholders are encouraged to proactively monitor the publication of all future Corporate Communications on the Websites for information. Solicitation of electronic contact details As a non-registered shareholder, if you wish to receive corporate communications from the Company pursuant to the Listing Rules, you should liaise with your bank(s), broker(s), custodian(s), nominee(s) or HKSCCNominees Limited through which your Shares are held (collectively, the “Intermediaries”) and provide your email address to your Intermediaries. If you want to receive the Corporate Communications in printed form, please complete and return the enclosed Reply Form to the Company’s Hong Kong share registrar (the “Share Registrar”), Computershare Hong Kong Investor Services Limited, at 17MFloor, Hopewell Centre,183 Queen’s Road East, Wan Chai, Hong Kong or send an email to guanzemedicalinformation.ecom@computershare.com.hk by specifying your name, address and request to receive the Corporate Communications in printed form. Should you have any queries relating to this letter, please send an email to guanzemedicalinformation.ecom@computershare.com.hk. Yours faithfully, On behalf of the Board Guanze Medical Information Industry (Holding) Co., Ltd. Meng Xianzhen Chairman of the Board 各位非登記持有人： Guanze Medical Information Industry (Holding) Co., Ltd.（「本公司」） –2023年報、通函（包括股東週年大會通告）（「本次公司通訊文件」）及環境、社會及管治報告（「2023年ESG報告」）之發佈通知 本公司的本次公司通訊文件備有中、英文版本，並已上載於香港聯合交易所有限公司網站（ ）（「披露易網站」）及本公司網站（）（「公司網站」），歡迎瀏覽。

閣下若因任何理由以致在获取載於本公司網站或披露易網站上的本次公司通訊文件出現困難，或希望收到本次公司通訊文件的印刷版， 閣下可將要求（註明 閣下的姓名、地址及要求）以電郵方式發送到本公司之電郵地址guanzemedicalinformation.ecom@computershare.com.hk或以書面方式郵寄致本公司的香港股份過戶登記處（「股份過戶處」）香港中央證券登記有限公司，地址為香港灣仔皇后大道東183號合和中心17M樓。

本公司將於接到 閣下通知後，盡快向 閣下免費發送有關本次公司通訊文件的印刷本。

本公司2023年ESG報告備有中、英文版本，僅以電子形式上載於披露易網站及本公司網站。

如 閣下有意免費收取本公司2023 ESG報告之印刷本，閣下可將要求（註明 閣下的姓名、地址及要求）以電郵方式發送到上述電郵地址或以書面方式郵寄致股份過戶處上述地址。

以電子方式發布公司通訊之安排 根據自2023年12月31日起生效的擴大無紙化制度及以電子方式發布公司通訊規定下香港聯合交易所有限公司證券上市規則（「上市規則」）第2.07A條，公司謹此通知 閣下，公司已採用以電子方式發布公司通訊（「公司通訊」）之安排，該公司通訊是指公司為向其任何證券持有人提供資訊或提醒其採取行動而發布或將要發布的任何文件，包括但不限於(a)董事報告、年度帳目以及審計報告副本以及（如適用）財務摘要報告；(b)中期報告及其中期報告摘要（如適用）；(c)會議通知；(d)上市文件；(e)通函和(f)委任表格。

請注意，所有未來公司通訊的英文版和中文版將在本公司網站和披露易網站（「網站」）上提供（「網站版」），以代替印刷本。

在對公司章程進行必要的修改後，公司將不再向公司股東發出網站版公司通訊的通知。

我們鼓勵股東主動留意網站上所有未來發佈的公司通訊以獲取資訊。

徵集電子聯絡資料 作為非登記股東，如有意根據《上市規則》收取公司通訊， 閣下應聯絡代 閣下持有股份的銀行、經紀、託管商、代理人或香港中央結算（代理人）有限公司（統稱「中介公司」），並向 閣下的中介公司提供 閣下的電子郵件地址。

若 閣下希望收取公司通訊之印刷本，請填妥本函背頁之回條並交回公司的香港股份過戶登記處（「股份過戶處」）香港中央證券登記有限公司，地址為香港灣仔皇后大道東183號合和中心17M樓或發送電子郵件至guanzemedicalinformation.ecom@computershare.com.hk，並註明 閣下的姓名、地址以及收取公司通訊印刷本的要求。

如 閣下對本函件有任何疑問，請發送電子郵件至guanzemedicalinformation.ecom@computershare.com.hk。

代表董事會 Guanze Medical Information Industry (Holding) Co., Ltd. 董事會主席孟憲震謹啟2024年4月30日Please cut the mailing label and stick it on an envelope to return this form to us. No postage is necessary if posted in Hong Kong. 當 閣下寄回此回條時，請將郵寄標籤剪貼於信封上。

如在本港投寄，閣下無需支付郵費或貼上郵票。

CCS6884 GAMH_NRH REPLYFORM 回條To: Computershare Hong Kong Investor Services Limited 致： 香港中央證券登記有限公司 (the “Share Registrar”) （「股份過戶處」） 17MFloor, Hopewell Centre香港灣仔皇后大道東183號183 Queen’s Road East, Wanchai, Hong Kong合和中心17M樓REMINDER 提示As a non-registered shareholder, if you wish to receive Corporate Communications* from the Company pursuant to the Listing Rules, you should liaise with your bank(s), broker(s), custodian(s), nominee(s) or HKSCCNominees Limited through which your shares are held (collectively, the “Intermediaries”) and provide your email address to your Intermediaries. 作為非登記股東，如有意根據《上市規則》收取公司通訊*， 閣下應聯絡 閣下持有股份的銀行、經紀、託管商、代理人或香港中央結算（代理人）有限公司（統稱「中介公司」），並向 閣下的中介公司提供 閣下的電子郵件地址。

Request for Corporate Communications* in printed form /要求收取公司通訊*印刷版(Please mark “” in the below box if applicable)（如適用，請在以下方格內劃上「」號） Name of the listed company (the “Company”) : 上市公司（「公司」）名稱： Guanze Medical Information Industry (Holding) Co., Ltd. I/we would like to receive future Corporate Communications* in printed form. 本人╱我們欲收取未來公司通訊*的印刷版。

Name(s) of Non-registered holder(s): 非登記股東姓名：Signature(s): (Note 3) 簽名：(附註3) (Please use ENGLISHBLOCKLETTERS請用英文正楷填寫) Contact number: 聯絡電話號碼：Date: 日期：Notes: 附註：1. This Reply Form is addressed to non-registered holder(s) (“Non-registered holder” means such person or company whose shares are held in The Central Clearing and Settlement System (CCASS) and who has notified the Company from time to time through Hong Kong Securities Clearing Company Limited that such pe rson or company wishes to receive Corporate Communications*). 此回條乃向本公司之非登記股東（「非登記股東」指股份存放於中央結算及交收系統的人士或公司，已透過香港中央結算有限公司不時向本公司發出通知，表示欲收取公司通訊*）發出。

2. Please complete all your details clearly. 請閣下清楚填妥所有資料。

3. Any form with no box marked (), with no signature or otherwise incorrectly completed will be void. 如在本表格未有在方格內劃上「 」號、或未有簽署、或在其他方面填寫不正確，則本表格將會作廢。

4. For the avoidance of doubt, the Company does not accept any other instructions given on this Reply Form. 為免存疑，在本回條上的任何額外指示，公司將不予處理。

* Unless otherwise specified, Corporate Communications refer to any documents issued or to be issued by the Company for the information or action of holders of any of its securities, including but not limited to the annual report, interim report, notice of meeting, circular and proxy form. 除非另有註明，公司通訊乃指公司已發出或將予發出以供其任何證券的持有人參照或採取行動的任何文件，其中包括但不限於年報、中期報告、會議通告、通函及代表委任表格。

PERSONALINFORMATIONCOLLECTIONSTATEMENT 收集個人資料聲明(i) “Personal Data” in this statement has the same meaning as “personal data” in the Personal Data (Privacy) Ordinance, Chapter 486 of the Laws of Hong Kong (“PDPO”). 本聲明中所指的「個人資料」與香港法例第486章《個人資料（私隱）條例》（「《私隱條例》」）中「個人資料」的涵義相同。

(ii) Your Personal Data provided in this Reply Form will be used in connection with the Company’s electronic dissemination of Corporate Communications*. Your supply of Personal Data to the Company is on a voluntary basis. In case of a failure to provide sufficient information, the Company may not be able to proce ss your instructions and/or requests as stated in this Reply Form. 閣下於本回條所提供的個人資料將用於有關公司以電子方式發布公司通訊*的事宜上。

閣下是自願向本公司提供個人資料。

若閣下未能提供足夠資料，本公司可能無法處理閣下在本回條上所述的指示及/或要求。

(iii) Your Personal Data may be disclosed or transferred by the Company to its subsidiaries, the Share Registrar, and/or other companies or bodies for any of the stated purposes, or when it is required to do so by law and will be retained for such period as may be necessary for our verification and record purposes. 公司可就任何所說明的用途或在法例規定的情況下，將 閣下的個人資料披露或轉移給公司的附屬公司、股份過戶處、及/或其他公司或團體，並將在適當期間保留該等個人資料作核實及紀錄用途。

(iv) You have the right to request access to and/or correction of your Personal Data in accordance with the provisions of th e PDPO. Any such request for access to and/or correction of your Personal Data should be in writing, by mail to the Hong Kong Privacy Officer of the Share Registrar at 17MFloor, Hopewell Centre,183 Queen’s Road East, Wanchai, Hong Kong or by email at PrivacyOfficer@computershare.com.hk. 閣下有權根據《私隱條例》的條文查閱及/或修改 閣下的個人資料。

任何該等查閱及/或修改個人資料的要求均須以書面方式郵寄至股份過戶處（地址為香港灣仔皇后大道東183號合和中心17M樓）向香港隱私主任提出，或發送電郵至PrivacyOfficer@computershare.com.hk。

Mailing Label Computershare Hong Kong Investor Services Freepost No. Hong Kong